eveloped a proprietary systematic delivery system to deliver molecules to targeted disease tissues and cells. The Company is lead drug partner with Quark & Pfizer and is on Phase I for PKN3-targeted cancer siRNA. • Alnylam Pharmaceuticals Inc (ALNY US) — is an early stage therapeutics company. The Company is